V. de Waard PhD publications

foto

Publications PhD V. de Waard

Positions
Associate Professor, Assistant Professor
Main activities
Education, Research
Specialisation
aneurysm development
Focus of research

Develop therapeutics that can reduce vessel wall degradation and thus decrease the growth (rate) of aortic aneurysms.

2021

  • Medzikovic Lejla, Heese Hylja, van Loenen Pieter B., van Roomen Cindy P. A. A., Hooijkaas Ingeborg B., Christoffels Vincent M., Creemers Esther E., de Vries Carlie J. M., de Waard Vivian Nuclear receptor nur77 controls cardiac fibrosis through distinct actions on fibroblasts and cardiomyocytes International journal of molecular sciences 2021;22 (4):1-16 [PubMed]

2020

  • van der Stoel Miesje, Schimmel Lilian, Nawaz Kalim, van Stalborch Anne-Marieke, de Haan Annett, Klaus-Bergmann Alexandra, Valent Erik T., Koenis Duco S., van Nieuw Amerongen Geerten P., de Vries Carlie J., de Waard Vivian, Gloerich Martijn, van Buul Jaap D., Huveneers Stephan DLC1 is a direct target of activated YAP/TAZ that drives collective migration and sprouting angiogenesis Journal of cell science 2020;133 (3) [PubMed]
  • van Andel Mitzi M, Indrakusuma Reza, Jalalzadeh Hamid, Balm Ron, Timmermans Janneke, Scholte Arthur J, van den Berg Maarten P, Zwinderman Aeilko H, Mulder Barbara J M, de Waard Vivian, Groenink Maarten Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial European heart journal 2020;41 (43):4181-4187 [PubMed]
  • Marinković Goran, Koenis Duco Steven, de Camp Lisa, Jablonowski Robert, Graber Naomi, de Waard Vivian, de Vries Carlie Jacoba, Goncalves Isabel, Nilsson Jan, Jovinge Stefan, Schiopu Alexandru S100A9 Links Inflammation and Repair in Myocardial Infarction Circulation research 2020;127 (5):664-676 [PubMed]

2019

  • de Waard Vivian, Postma Alex V. Editorial commentary: Another notch for bicuspid aortic valve aortopathy? Trends in cardiovascular medicine 2019;29 (2):69-70 [PubMed]
  • Yin 殷晓科 Xiaoke, Wanga Shaynah, Fellows Adam L., Barallobre-Barreiro Javier, Lu Ruifang, Davaapil Hongorzul, Franken Romy, Fava Marika, Baig Ferheen, Skroblin Philipp, Xing Qiuru, Koolbergen David R., Groenink Maarten, Zwinderman Aeilko H., Balm Ron, de Vries Carlie J. M., Mulder Barbara J. M., Viner Rosa, Jahangiri Marjan, Reinhardt Dieter P., Sinha Sanjay, de Waard Vivian, Mayr Manuel Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients Arteriosclerosis, thrombosis, and vascular biology 2019;39 (9):1859-1873 [PubMed]
  • Medzikovic Lejla, de Vries Carlie J. M., de Waard Vivian NR4A nuclear receptors in cardiac remodeling and neurohormonal regulation Trends in cardiovascular medicine 2019;29 (8):429-437 [PubMed]
  • Hibender Stijntje, Wanga Shaynah, van der Made Ingeborg, Vos Mariska, Mulder Barbara J. M., Balm Ron, de Vries Carlie J. M., de Waard Vivian Renal cystic disease in the Fbn1C1039G/+ Marfan mouse is associated with enhanced aortic aneurysm formation Cardiovascular pathology 2019;38:1-6 [PubMed]
  • van Andel Mitzi M., Groenink Maarten, Zwinderman Aeilko H., Mulder Barbara J.M., de Waard Vivian The potential beneficial effects of resveratrol on cardiovascular complications in marfan syndrome patients–insights from rodent-based animal studies International journal of molecular sciences 2019;20 (5) [PubMed]
  • Tedjawirja Victoria N., de Waard Vivian Which Mouse Model of Abdominal Aortic Aneurysm Deserves Triple A Status? European journal of vascular and endovascular surgery 2019 [PubMed]

2018

  • van Puijvelde Gijs H. M., Foks Amanda C., van Bochove Rosemarie E., Bot Ilze, Habets Kim L. L., de Jager Saskia C., ter Borg Mariëtte N. D., van Osch Puck, Boon Louis, Vos Mariska, de Waard Vivian, Kuiper Johan CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice PLoS ONE 2018;13 (1):e0190962 [PubMed]
  • Kusters Pascal J. H., Seijkens Tom T. P., Beckers Linda, Lievens Dirk, Winkels Holger, de Waard Vivian, Duijvestijn Adriaan, Liljeqvist Moritz Lindquist, Roy Joy, Daugherty Alan, Newby Andrew, Gerdes Norbert, Lutgens Esther CD40L deficiency protects against aneurysm formation Arteriosclerosis, thrombosis, and vascular biology 2018;38 (5):1076-1085 [PubMed]
  • Schimmel Lilian, de Ligt Aafke, Tol Simon, de Waard Vivian, van Buul Jaap D. Endothelial RhoB and RhoC are dispensable for leukocyte diapedesis and for maintaining vascular integrity during diapedesis Small GTPases 2018:on-line [PubMed]
  • Medzikovic Lejla Nuclear receptor Nur77 at the heart of cardiac disease modulation 2018. ISBN 9789463750417. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Vries C. J. M., de Winter R. J.; Co-supervisors: de Waard V., Arkenbout E. K.)
  • Koenis Duco S. Nuclear receptors and their co-factors in hematological and inflammation-driven disorders 2018. ISBN 9789463750202. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Vries C. J. M., Zelcer N.; Co-supervisors: de Waard V., Huveneers S.)
  • Medzikovic Lejla, van Roomen Cindy, Baartscheer Antonius, van Loenen Pieter B, de Vos Judith, Bakker Erik N T P, Koenis Duco S, Damanafshan Amin, Creemers Esther E, Arkenbout E Karin, de Vries Carlie J M, de Waard Vivian Nur77 protects against adverse cardiac remodelling by limiting neuropeptide Y signalling in the sympathoadrenal-cardiac axis Cardiovascular research 2018;114 (12):1617-1628 [PubMed]
  • Koenis Duco S., Medzikovic Lejla, Vos Mariska, Beldman Thijs J., van Loenen Pieter B., van Tiel Claudia M., Hamers Anouk A. J., Rubio Iker Otermin, de Waard Vivian, de Vries Carlie J. M. Nur77 variants solely comprising the amino-terminal domain activate hypoxia-inducible factor-1 α and affect bone marrow homeostasis in mice and humans Journal of biological chemistry 2018;293 (39):15070-15083 [PubMed]
  • Schimmel Lilian, van der Stoel Miesje, Rianna Carmela, van Stalborch Anne-Marieke, de Ligt Aafke, Hoogenboezem Mark, Tol Simon, van Rijssel Jos, Szulcek Robert, Bogaard Harm Jan, Hofmann Patrick, Boon Reinier, Radmacher Manfred, de Waard Vivian, Huveneers Stephan, van Buul Jaap D. Stiffness-Induced Endothelial DLC-1 Expression Forces Leukocyte Spreading through Stabilization of the ICAM-1 Adhesome Cell reports 2018;24 (12):3115-3124 [PubMed]
  • Palao Teresa, Medzikovic Lejla, Rippe Catarina, Wanga Shaynah, Al-Mardini Claudia, van Weert Angela, de Vos Judith, van der Wel Nicole N., van Veen Henk A., van Bavel Ed T., Swärd Karl, de Waard Vivian, Bakker Erik N. TP Thrombospondin-4 mediates cardiovascular remodelling in angiotensin II-induced hypertension Cardiovascular pathology 2018;35:12-19 [PubMed]

2017

  • Wanga Shaynah, Hibender Stijntje, Ridwan Yanto, van Roomen Cindy, Vos Mariska, van der Made Ingeborg, van Vliet Nicole, Franken Romy, van Riel Luigi Amjg, Groenink Maarten, Zwinderman Aeilko H., Mulder Barbara Jm, de Vries Carlie Jm, Essers Jeroen, de Waard Vivian Aortic microcalcification is associated with elastin fragmentation in Marfan syndrome Journal of pathology 2017;243 (3):294-306 [PubMed]
  • Wanga S., de Waard V. Bile-ated Cell Death Decreases Aortic Aneurysm Formation European journal of vascular and endovascular surgery 2017;53 (3):346 [PubMed]
  • Kroon Jeffrey, Heemskerk Niels, Kalsbeek Martin J. T., de Waard Vivian, van Rijssel Jos, van Buul Jaap D. Flow-induced endothelial cell alignment requires the RhoGEF Trio as a scaffold protein to polarize active Rac1 distribution Molecular biology of the cell 2017;28 (13):1745-1753 [PubMed]
  • den Hartog Alexander W. Losartan in Marfan syndrome 2017. 156p. ISBN 9789492683199. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Mulder B. J. M., Zwinderman A. H.; Co-supervisors: Groenink M., de Waard V.)
  • de Waard Vivian Marfan on the Move Journal of the American Heart Association 2017;6 (9) [PubMed]
  • Hakimzadeh Nazanin, Pinas Victorine A., Molenaar Ger, de Waard Vivian, Lutgens Esther, van Eck-Smit Berthe L. F., de Bruin Kora, Piek Jan J., Eersels Jos L. H., Booij Jan, Verberne Hein J., Windhorst Albert D. Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques PLoS ONE 2017;12 (11) [PubMed]

2016

  • Hibender Stijntje Exploring novel treatments to prevent aortic aneurysm growth in Marfan syndrome 2016. 169p. ISBN 9789461699640. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Vries C. J. M., Mulder B. J. M.; Co-supervisor: de Waard V.)
  • Franken Romy, Groenink Maarten, de Waard Vivian, Feenstra Helena M. A., Scholte Arthur J., van den Berg Maarten P., Pals Gerard, Zwinderman Aeilko H., Timmermans Janneke, Mulder Barbara J. M. Genotype impacts survival in Marfan syndrome European heart journal 2016;37 (43):3285-3290 [PubMed]
  • Ruiter Matthijs S., Doornbos Albert, de Waard Vivian, de Winter Robbert J., Attevelt Nico J. M., Steendam Rob, de Vries Carlie J. M. Long-term effect of stents eluting 6-mercaptopurine in porcine coronary arteries Journal of negative results in biomedicine 2016;15 (1):20 [PubMed]
  • Franken Romy Marfan syndrome: Getting to the root of the problem 2016. 205p. ISBN 9789461697431. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Mulder B. J. M., Zwinderman A. H.; Co-supervisors: Groenink M., de Waard V.)
  • Wanga Shaynah, Silversides Candice, Dore Annie, de Waard Vivian, Mulder Barbara Pregnancy and Thoracic Aortic Disease: Managing the Risks Canadian journal of cardiology 2016;32 (1):78-85 [PubMed]
  • Hibender Stijntje, Franken Romy, van Roomen Cindy, ter Braake Anique, van der Made Ingeborg, Schermer Edith E., Gunst Quinn, van den Hoff Maurice J., Lutgens Esther, Pinto Yigal M., Groenink Maarten, Zwinderman Aeilko H., Mulder Barbara J. M., de Vries Carlie J. M., de Waard Vivian Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model Arteriosclerosis, thrombosis, and vascular biology 2016;36 (8):1618-1626 [PubMed]
  • den Hartog A. W., Franken R., van den Berg M. P., Zwinderman A. H., Timmermans J., Scholte A. J., de Waard V., Spijkerboer A. M., Pals G., Mulder B. J. M., Groenink M. The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations Netherlands heart journal 2016;24 (11):675-681 [PubMed]

2015

  • Franken Romy, den Hartog Alexander W., Radonic Teodora, Micha Dimitra, Maugeri Alessandra, van Dijk Fleur S., Meijers-Heijboer Hanne E., Timmermans Janneke, Scholte Arthur J., van den Berg Maarten P., Groenink Maarten, Mulder Barbara J. M., Zwinderman Aeilko H., de Waard Vivian, Pals Gerard Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome Circulation. Cardiovascular genetics 2015;8 (2):383-388 [PubMed]
  • Franken Romy, El Morabit Abdelali, de Waard Vivian, Timmermans Janneke, Scholte Arthur J., van den Berg Maarten P., Marquering Henk, Planken Nils R. N., Zwinderman Aeilko H., Mulder Barbara J. M., Groenink Maarten Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome International journal of cardiology 2015;194:7-12 [PubMed]
  • Kurakula Konda Babu Nur77 and FHL2: Novel players in vascular and immune disease 2015. 313p. ISBN 9789462330122. [UvA Dissertations Online] University of Amsterdam. (Supervisor: de Vries C. J. M.; Co-supervisors: van Tiel C. M., de Waard V.)
  • Medzikovic Lejla, Schumacher Cees A., Verkerk Arie O., van Deel Elza D., Wolswinkel Rianne, van der Made Ingeborg, Bleeker Natascha, Cakici Daniella, van den Hoogenhof Maarten M. G., Meggouh Farid, Creemers Esther E., Remme Carol Ann, Baartscheer Antonius, de Winter Robbert J., de Vries Carlie J. M., Arkenbout E. Karin, de Waard Vivian Orphan nuclear receptor Nur77 affects cardiomyocyte calcium homeostasis and adverse cardiac remodelling Scientific reports 2015;5:15404 [PubMed]
  • Hamers Anouk Anna Johanna Role of nuclear receptor Nur77 during inflammation 2015. 203p. ISBN 9789461089106. [UvA Dissertations Online] University of Amsterdam. (Supervisor: de Vries C. J. M.; Co-supervisor: de Waard V.)
  • Ruiter Matthijs S., van Tiel Claudia M., Doornbos Albert, Marinković Goran, Strang Aart C., Attevelt Nico J. M., de Waard Vivian, de Winter Robbert J., Steendam Rob, de Vries Carlie J. M. Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits PLoS ONE 2015;10 (9):e0138459 [PubMed]
  • Marinković Goran, Heemskerk Niels, van Buul Jaap D., de Waard Vivian The Ins and Outs of Small GTPase Rac1 in the Vasculature Journal of pharmacology and experimental therapeutics 2015;354 (2):91-102 [PubMed]
  • Franken R., Radonic T., den Hartog A. W., Groenink M., Pals G., van Eijk M., Lutter R., Mulder B. J. M., Zwinderman A. H., de Waard V. The revised role of TGF-β in aortic aneurysms in Marfan syndrome Netherlands heart journal 2015;23 (2):116-121 [PubMed]
  • den Hartog Alexander W., Franken Romy, Zwinderman Aeilko H., Timmermans Janneke, Scholte Arthur J., van den Berg Maarten P., de Waard Vivian, Pals Gerard, Mulder Barbara J. M., Groenink Maarten The risk for type B aortic dissection in Marfan syndrome Journal of the American College of Cardiology 2015;65 (3):246-254 [PubMed]
  • Marinković Goran Thiopurines and inhibition of Rac1 in vascular disease 2015. 169p. ISBN 9788687471320. [UvA Dissertations Online] University of Amsterdam. (Supervisor: de Vries C. J. M.; Co-supervisors: de Waard V., van Buul J. D.)

2014

  • Marinković Goran, Hamers Anouk A. J., de Vries Carlie J. M., de Waard Vivian 6-Mercaptopurine reduces macrophage activation and gut epithelium proliferation through inhibition of GTPase Rac1 Inflammatory bowel diseases 2014;20 (9):1487-1495 [PubMed]
  • Franken Romy, Heesterbeek Thomas J., de Waard Vivian, Zwinderman Aeilko H., Pals Gerard, Mulder Barbara J. M., Groenink Maarten Diagnosis and genetics of Marfan syndrome Expert opinion on orphan drugs 2014;2 (10):1049-1062
  • Franken R., den Hartog A. W., Radonic T., de Waard V., Timmermans J., Scholte A. J., van den Berg M. P., Zwinderman A. H., Mulder B. J. M., Groenink M. Effect van behandeling met losartan op aortadilatatie bij volwassenen met het Marfan-syndroom* Nederlands tijdschrift voor geneeskunde 2014;158 (2):A6845-(7 p.) [PubMed]
  • Franken Romy, Den Hartog Alexander W., Radonic Teodora, De Waard Vivian, Timmermans Janneke, Scholte Arthur J., Van Den Berg Maarten P., Zwinderman Aeilko H., Mulder Barbara J.M., Groenink Maarten Effectvan behandeling met losartan op aortadilatatie bij volwassenen met het Marfan-syndroom Nederlands tijdschrift voor geneeskunde 2014;158 (4)
  • Marinković Goran, Kroon Jeffrey, Hoogenboezem Mark, Hoeben Kees A., Ruiter Matthijs S., Kurakula Kondababu, Otermin Rubio Iker, Vos Mariska, de Vries Carlie J. M., van Buul Jaap D., de Waard Vivian Inhibition of GTPase Rac1 in endothelium by 6-mercaptopurine results in immunosuppression in nonimmune cells: new target for an old drug Journal of immunology (Baltimore, Md. 2014;192 (9):4370-4378 [PubMed]
  • Franken Romy, Hibender Stijntje, den Hartog Alexander W., Radonic Teodora, de Vries Carlie J. M., Zwinderman Aeilko H., Groenink Maarten, Mulder Barbara J. M., de Waard Vivian No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice PLoS ONE 2014;9 (9):e107221-(7 p.) [PubMed]
  • Kurakula Kondababu, Vos Mariska, Otermin Rubio Iker, Marinković Goran, Buettner Reinhard, Heukamp Lukas C., Stap Jan, de Waard Vivian, van Tiel Claudia M., de Vries Carlie J. M. The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells PLoS ONE 2014;9 (4):e94931-(9 p.) [PubMed]

2013

  • Franken Romy, den Hartog Alexander W., de Waard Vivian, Engele Leo, Radonic Teodora, Lutter Rene, Timmermans Janneke, Scholte Arthur J., van den Berg Maarten P., Zwinderman Aeilko H., Groenink Maarten, Mulder Barbara J. M. Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome International journal of cardiology 2013;168 (3):2441-2446 [PubMed]
  • Franken Romy, den Hartog Alexander W., van de Riet Liz, Timmermans Janneke, Scholte Arthur J., van den Berg Maarten P., de Waard Vivian, Zwinderman Aeilko H., Groenink Maarten, Yip James W., Mulder Barbara J. M. Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome Circulation journal 2013;77 (11):2793-2798 [PubMed]
  • Marinkovic Goran, Hibender Stijntje, Hoogenboezem Mark, van Broekhoven Amber, Girigorie Arginell F., Bleeker Natascha, Hamers Anouk A. J., Stap Jan, van Buul Jaap D., de Vries Carlie J. M., de Waard Vivian Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells Arteriosclerosis, thrombosis, and vascular biology 2013;33 (10):2380-2388 [PubMed]
  • Groenink Maarten, den Hartog Alexander W., Franken Romy, Radonic Teodora, de Waard Vivian, Timmermans Janneke, Scholte Arthur J., van den Berg Maarten P., Spijkerboer Anje M., Marquering Henk A., Zwinderman Aeilko H., Mulder Barbara J. M. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial European heart journal 2013;34 (45):3491-3500 [PubMed]
  • Kurakula Kondababu, Hamers Anouk A. J., de Waard Vivian, de Vries Carlie J. M. Nuclear Receptors in atherosclerosis: a superfamily with many 'Goodfellas' Molecular and cellular endocrinology 2013;368 (1-2):71-84 [PubMed]

2012

  • Hamers Anouk A. J., Vos Mariska, Rassam Fadi, Marincovic Goran, Kurakula Kondababu, van Gorp Patrick J., de Winther Menno P. J., Gijbels Marion J. J., de Waard Vivian, de Vries Carlie J. M. Bone Marrow-Specific Deficiency of Nuclear Receptor Nur77 Enhances Atherosclerosis Circulation research 2012;110 (3):428-U147 [PubMed]
  • Radonic Teodora, de Witte Piet, Groenink Maarten, de Waard Vivian, Lutter Rene, van Eijk Marco, Jansen Marnix, Timmermans Janneke, Kempers Marlies, Scholte Arthur J., Hilhorst-Hofstee Yvonne, van den Berg Maarten P., van Tintelen J. Peter, Pals Gerard, Baars Marieke J. H., Mulder Barbara J. M., Zwinderman Aeilko H. Inflammation Aggravates Disease Severity in Marfan Syndrome Patients PLoS ONE 2012;7 (3):e32963-(9 p.) [PubMed]
  • de Waard Vivian, Gijbels Marion J. J., Lutgens Esther, de Winther Menno P. J., de Vries Carlie J. M. Models and Analysis of Atherosclerosis, Restenosis, and Aneurysm Formation in the Mouse Current protocols in mouse biology 2012;2 (4):317-345 [PubMed]

2011

  • Pinas Victorine A. Development of a potent series of MMP-2 and MMP-9 selective inhibitors. MMP-2 and MMP-9 visualization in unstables plaques using PET and SPECT is approaching 2011. 152p. ISBN 9789086494583. [UvA Dissertations Online] Katholiieke Universiteit Leuven: Dept. Organic Synthesis, Fac. of Science. (Supervisor: Dehaen W.; Co-supervisor: de Waard V.)
  • de Jager Saskia C. A., Bermúdez Beatriz, Bot Ilze, Koenen Rory R., Bot Martine, Kavelaars Annemieke, de Waard Vivian, Heijnen Cobi J., Muriana Francisco J. G., Weber Christian, van Berkel Theo J. C., Kuiper Johan, Lee Se-Jin, Abia Rocio, Biessen Erik A. L. Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis Journal of experimental medicine 2011;208 (2):217-225 [PubMed]
  • Wolthuis Esther K., Vlaar Alexander P. J., Hofstra Jorrit-Jan H., Roelofs Joris J. T. H., de Waard Vivian, Juffermans Nicole P., Schultz Marcus J. Plasminogen activator inhibitor-type I gene deficient mice show reduced influx of neutrophils in ventilator-induced lung injury Critical care research and practice 2011;2011:217896 [PubMed]

2010

  • Pols Thijs W. H., Bonta Peter I., Pires Nuno M. M., Otermin Iker, Vos Mariska, de Vries Margreet R., van Eijk Marco, Roelofsen Jeroen, Havekes Louis M., Quax Paul H. A., van Kuilenburg André B. P., de Waard Vivian, Pannekoek Hans, de Vries Carlie J. M. 6-Mercaptopurine Inhibits Atherosclerosis in Apolipoprotein E*3-Leiden Transgenic Mice Through Atheroprotective Actions on Monocytes and Macrophages Arteriosclerosis, thrombosis, and vascular biology 2010;30 (8):1591-1597 [PubMed]
  • Janmaat Maarten L., Heerkens Jasper L. T., de Bruin Alexander M., Klous Anita, de Waard Vivian, de Vries Carlie J. M. Erythropoietin accelerates smooth muscle cell-rich vascular lesion formation in mouse through endothelial cell activation involving enhanced PDGF-BB release Blood 2010;115 (7):1453-1460 [PubMed]
  • de Waard Vivian, Bot Ilze, de Jager Saskia C. A., Talib Sara, Egashira Kensuke, de Vries Margreet R., Quax Paul H. A., Biessen Erik A. L., van Berkel Theo J. C. Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently Atherosclerosis 2010;211 (1):84-89 [PubMed]

2008

  • Out Ruud, Hoekstra Menno, Habets Kim, Meurs Illiana, de Waard Vivian, Hildebrand Reeni B., Wang Yanan, Chimini Giovanna, Kuiper Johan, van Berkel Theo J. C., van Eck Miranda Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels Arteriosclerosis, thrombosis, and vascular biology 2008;28 (2):258-264 [PubMed]

2006

  • de Waard Vivian, Hansen Hjalmar R., Spronk Henri H. M., Timmerman Janneke J., Pannekoek Hans, Florquin Sandrine, Reitsma Pieter H., ten Cate Hugo Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited Thrombosis and haemostasis 2006;95 (2):348-353 [PubMed]
  • de Waard Vivian, Arkenbout E. Karin, Vos Mariska, Mocking Astrid I. M., Niessen Hans W. M., Stooker Wim, de Mol Bas A. J. M., Quax Paul H. A., Bakker Erik N. T. P., VanBavel Ed, Pannekoek Hans, de Vries Carlie J. M. TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells American journal of pathology 2006;168 (6):2027-2035 [PubMed]

2005

  • Guo Jian, de Waard Vivian, van Eck Miranda, Hildebrand Reeni B., van Wanrooij Eva J. A., Kuiper Johan, Maeda Nobuyo, Benson G. Martin, Groot Pieter H. E., van Berkel Theo J. C. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development Arteriosclerosis, thrombosis, and vascular biology 2005;25 (5):1014-1019 [PubMed]
  • Guo Jian, van Eck Miranda, de Waard Vivian, Maeda Nobuyo, Benson G. Martin, Groot Pieter H. E., van Berkel Theo J. C. The presence of leukocyte CC-chemokine receptor 2 in CCR2 knockout mice promotes atherogenesis BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 2005;1740 (3):453-459 [PubMed]
  • Renckens R., Roelofs J. J. T. H., de Waard V., Florquin S., Lijnen H. R., Carmeliet P., van der Poll T. The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury Journal of thrombosis and haemostasis 2005;3 (5):1018-1025 [PubMed]

2003

  • de Waard Vivian, van Achterberg Tanja A. E., Beauchamp Nicholas J., Pannekoek Hans, de Vries Carlie J. M. Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions - Activin induces carp in smooth muscle cells Arteriosclerosis, thrombosis, and vascular biology 2003;23 (1):64-68 [PubMed]
  • Rijneveld Anita W., Florquin Sandrine, Bresser Paul, Levi Marcel, de Waard Vivian, Lijnen Roger, van der Zee Jaring S., Speelman Peter, Carmeliet Peter, van der Poll Tom Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia Blood 2003;102 (3):934-939 [PubMed]

2002

  • de Waard V. Activation mechanisms in vascular disease 2002. 128p. ISBN 9789090158235. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Pannekoek H.)
  • de Waard Vivian, Arkenbout E. Karin, Carmeliet Peter, Lindner Volkhard, Pannekoek Hans Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model Arteriosclerosis, thrombosis, and vascular biology 2002;22 (12):1978-1983 [PubMed]
  • Arkenbout E. Karin, de Waard Vivian, van Bragt Maaike, van Achterberg Tanja A. E., Grimbergen Jos M., Pichon Bruno, Pannekoek Hans, de Vries Carlie J. M. Protective function of transcription factor TR3 orphan receptor in atherogenesis - Decreased lesion formation in carotid artery ligation model in TR3 transgenic mice Circulation 2002;106 (12):1530-1535 [PubMed]
  • de Waard V., Beauchamp N. J., van Zonneveld A. J., Pannekoek H. Serial analysis of gene expression (SAGE)in: S. Lorkowski, P. Cullen, editors. Analysing gene expression: a handbook of methods, possibilities and pitfals. Weinheim: Wiley VCH Publishers; 2002. p. 143-149, ISBN 9783527304882

2001

  • Boxman I. L., Mulder L. H., Noya F., de Waard V., Gibbs S., Broker T. R., ten Kate F., Chow L. T., ter Schegget J. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures Journal of investigative dermatology 2001;117 (6):1397-1404 [PubMed]

1999

  • de Waard V., van den Berg B. M., Veken J., Schultz-Heienbrok R., Pannekoek H., van Zonneveld A. J. Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus Gene 1999;226 (1):1-8 [PubMed]

1998

  • Yamamoto K., de Waard V., Fearns C., Loskutoff D. J. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo Blood 1998;92 (8):2791-2801 [PubMed]

1997

  • Hop C., de Waard V., van Mourik J. A., Pannekoek H. Lack of gradual regulation of tetracycline-controlled gene expression by the tetracyclin-repressor/VP16 transactivator (tTA) in cultured cells FEBS letters 1997;405 (2):167-171 [PubMed]